View
71
Download
0
Category
Preview:
DESCRIPTION
What Does BRCA Have to Do With It? PARP Inhibitors in Ovarian Cancer. Program Goals. Ovarian Cancer Overview. PARP Inhibition in Ovarian Cancer. Testing for BRCA1/2 Mutations. PARP Inhibitors Under Development. Olaparib in Patients With BRCA1 / BRCA2 Ovarian Cancer. - PowerPoint PPT Presentation
Citation preview
What Does BRCA Have to Do With It? PARP Inhibitors in
Ovarian Cancer
Program Goals
Ovarian Cancer Overview
PARP Inhibition in Ovarian Cancer
Testing for BRCA1/2 Mutations
PARP Inhibitors Under Development
Olaparib in Patients With BRCA1/BRCA2 Ovarian Cancer
PARP Inhibitors in Patients With BRCA1/BRCA2 Ovarian Cancer
PARP Inhibitors as Maintenance Therapy
Biomarkers to Measure PARP Inhibitor Response
PARP Inhibitors and Chemotherapy
Olaparib Maintenance Therapy
Velaparib in Patients With Recurrent Disease
Major Toxicities of PARP Inhibitors
Outstanding Questions
Abbreviations
References
References (cont)
References (cont)
References (cont)
Recommended